Three House Democrats Seek To Stall Azar Nomination Over Insulin Price Hikes

November 29, 2017
Three of Congress' most liberal Democrats urged heads of key committees to hold up the confirmation of Alex Azar as the next HHS secretary until investigations by five state attorneys general, which the lawmakers allege may deal with price fixing of insulin, are resolved. “Alex Azar's role and Eli Lilly's involvement in price gouging must be fully investigated and revealed before he is put in charge of overseeing American's health needs. We strongly urge you not to confirm Alex Azar's...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.